Mariner
ARKG icon

Mariner’s ARK Genomic Revolution ETF ARKG Stock Holding History

Mariner’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Sell
15,180
-44,436
-75% -$1.42M ﹤0.01% 2297
2026
Q1 		$1.58M Buy
59,616
+6,053
+11% +$177K ﹤0.01% 1664
2025
Q4 		$1.55M Buy
53,563
+15,880
+42% +$477K ﹤0.01% 1650
2025
Q3 		$1.05M Buy
37,683
+5,527
+17% +$140K ﹤0.01% 1871
2025
Q2 		$783K Sell
32,156
-14,416
-31% -$316K ﹤0.01% 1987
2025
Q1 		$967K Buy
46,572
+41
+0.1% +$1.03K ﹤0.01% 1711
2024
Q4 		$1.1M Sell
46,531
-10,691
-19% -$263K ﹤0.01% 1580
2024
Q3 		$1.46M Sell
57,222
-22,176
-28% -$565K ﹤0.01% 1360
2024
Q2 		$1.86M Sell
79,398
-17,836
-18% -$450K ﹤0.01% 1146
2024
Q1 		$2.8M Sell
97,234
-1,916
-2% -$57.6K 0.01% 949
2023
Q4 		$3.25M Sell
99,150
-3,034
-3% -$82.5K 0.01% 849
2023
Q3 		$2.85M Buy
102,184
+47
+0% +$1.54K 0.01% 830
2023
Q2 		$3.48M Buy
102,137
+31,276
+44% +$983K 0.01% 771
2023
Q1 		$2.13M Buy
70,861
+860
+1% +$26.6K 0.01% 929
2022
Q4 		$1.98M Buy
70,001
+57,230
+448% +$1.82M 0.01% 931
2022
Q3 		$420K Sell
12,771
-2,326
-15% -$85.4K ﹤0.01% 1520
2022
Q2 		$475K Sell
15,097
-735
-5% -$25.7K ﹤0.01% 1145
2022
Q1 		$727K Sell
15,832
-5,637
-26% -$269K ﹤0.01% 1024
2021
Q4 		$1.31M Buy
21,469
+9,405
+78% +$650K 0.01% 756
2021
Q3 		$901K Sell
12,064
-327
-3% -$27.4K ﹤0.01% 727
2021
Q2 		$1.15M Sell
12,391
-2,027
-14% -$172K 0.01% 633
2021
Q1 		$1.28M Sell
14,418
-55,985
-80% -$5.55M 0.01% 553
2020
Q4 		$6.57M Buy
+70,403
New +$5.61M 0.05% 256

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mariner's ARKG Position: Q2 2026 in Review

Mariner reduced its ARK Genomic Revolution ETF (ARKG) stake by 75% in Q2 2026, selling an estimated $1.42M and leaving 15,180 shares worth $638K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

Mariner first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $6.57M in Q4 2020. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Mariner held 15,180 shares of ARK Genomic Revolution ETF worth $638K as of Q2 2026.
  • Mariner sold 44,436 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.42M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2297 holding.
  • Mariner first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Mariner's ARK Genomic Revolution ETF position peaked at $6.57M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.